Radiation therapy results in preferential tumor antigen-specific lymphodepletion in head and neck cancer.Published in:Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60827-wBy:Zenga, Joseph;Awan, Musaddiq J.;Frei, Anne;Foeckler, Jamie;Kuehn, Rachel;Kasprzak, Julia;Massey, Becky;Bruening, Jennifer;Akakpo, Kenneth;Shukla, Monica;Wong, Stuart J.;Mathison, Angela J.;Wendt Andrae, Jaime;Hunt, Bryan;Puzyrenko, Andrii;Jin, Victor X.;Memon, Abdullah A.;Villarreal Espinosa, Oscar;Chen, Fanghong;Shaheduzzaman, MdPublication type:Article